Activation of HIV-1 from Latent Infection via Synergy of RUNX1 Inhibitor Ro5-3335 and SAHA
Zachary Klase(University of the Sciences), Kuan‐Teh Jeang(National Institutes of Health), Laurent Houzet(National Institutes of Health), Frank Maldarelli(Cancer Institute (WIA)), Jason M. Brenchley(Office of Extramural Research), Molly Perkins(National Institutes of Health), Venkat S. R. K. Yedavalli(National Institutes of Health), Paul Liu(National Institutes of Health), Klaus Strebel(National Institute of Allergy and Infectious Diseases)
Cited by 67
Related Papers
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
|Nature Medicine|2006|3.6k
CD4+ T Cell Depletion during all Stages of HIV Disease Occurs Predominantly in the Gastrointestinal Tract
|The Journal of Experimental Medicine|2004|1.8k
HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation
|Nature Medicine|2009|1.7k
Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation
|Journal of Immunological Methods|2003|1.6k
HIV preferentially infects HIV-specific CD4+ T cells
|Nature|2002|1.3k